within Pharmacolibrary.Drugs.S_SensoryOrgans.S01J_DiagnosticAgents.S01JA02_RoseBengalSodium;

model RoseBengalSodium
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 1.944444444444445e-06,
    adminDuration = 600,
    adminMass = 1 / 1000000,
    adminCount = 1,
    Vd = 5e-05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>RoseBengalSodium</td></tr><tr><td>ATC code:</td><td>S01JA02</td></tr><td>route:</td><td>ocular</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>1</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.05</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.1</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Rose bengal sodium is a synthetic xanthene dye, primarily used as a diagnostic staining agent in ophthalmology for evaluating eye surface damage and dry eye, and has also been investigated as a therapeutic agent for certain cancers (e.g., metastatic melanoma) under the name PV-10. It is mainly approved as a diagnostic ocular agent and is not an approved systemic therapeutic drug.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data for rose bengal sodium as an ophthalmic agent in humans. Estimates based on general physicochemical and use characteristics.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.S.S01JA02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end RoseBengalSodium;
